443 related articles for article (PubMed ID: 21036945)
1. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.
Asaga S; Kuo C; Nguyen T; Terpenning M; Giuliano AE; Hoon DS
Clin Chem; 2011 Jan; 57(1):84-91. PubMed ID: 21036945
[TBL] [Abstract][Full Text] [Related]
2. Direct serum assay for microRNA in cancer patients.
Asaga S; Hoon DS
Methods Mol Biol; 2013; 1024():147-55. PubMed ID: 23719948
[TBL] [Abstract][Full Text] [Related]
3. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.
Eichelser C; Flesch-Janys D; Chang-Claude J; Pantel K; Schwarzenbach H
Clin Chem; 2013 Oct; 59(10):1489-96. PubMed ID: 23748853
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA-155 as a potential biomarker to track disease in breast cancer.
Sun Y; Wang M; Lin G; Sun S; Li X; Qi J; Li J
PLoS One; 2012; 7(10):e47003. PubMed ID: 23071695
[TBL] [Abstract][Full Text] [Related]
5. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
Mar-Aguilar F; Mendoza-Ramírez JA; Malagón-Santiago I; Espino-Silva PK; Santuario-Facio SK; Ruiz-Flores P; Rodríguez-Padilla C; Reséndez-Pérez D
Dis Markers; 2013; 34(3):163-9. PubMed ID: 23334650
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer.
Anwar SL; Tanjung DS; Fitria MS; Kartika AI; Sari DNI; Rakhmina D; Wardana T; Astuti I; Haryana SM; Aryandono T
Asian Pac J Cancer Prev; 2020 Feb; 21(2):491-497. PubMed ID: 32102529
[TBL] [Abstract][Full Text] [Related]
7. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
[TBL] [Abstract][Full Text] [Related]
8. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
10. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
Markou A; Zavridou M; Sourvinou I; Yousef G; Kounelis S; Malamos N; Georgoulias V; Lianidou E
Clin Chem; 2016 Jul; 62(7):1002-11. PubMed ID: 27197674
[TBL] [Abstract][Full Text] [Related]
11. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer.
Zhao FL; Hu GD; Wang XF; Zhang XH; Zhang YK; Yu ZS
J Int Med Res; 2012; 40(3):859-66. PubMed ID: 22906258
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
Shaker O; Maher M; Nassar Y; Morcos G; Gad Z
Gene; 2015 Apr; 560(1):77-82. PubMed ID: 25644077
[TBL] [Abstract][Full Text] [Related]
13. Circulating status of microRNAs 660-5p and 210-3p in breast cancer patients.
Nashtahosseini Z; Aghamaali MR; Sadeghi F; Heydari N; Parsian H
J Gene Med; 2021 Apr; 23(4):e3320. PubMed ID: 33533518
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
15. Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.
Toraih EA; Mohammed EA; Farrag S; Ramsis N; Hosny S
Mol Diagn Ther; 2015 Jun; 19(3):179-90. PubMed ID: 26063582
[TBL] [Abstract][Full Text] [Related]
16. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
17. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
[TBL] [Abstract][Full Text] [Related]
18. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison.
Arabkari V; Clancy E; Dwyer RM; Kerin MJ; Kalinina O; Holian E; Newell J; Smith TJ
Pathol Oncol Res; 2020 Apr; 26(2):833-844. PubMed ID: 30840191
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea.
Kim J; Park S; Hwang D; Kim SI; Lee H
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32659906
[No Abstract] [Full Text] [Related]
20. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer.
Huang SK; Luo Q; Peng H; Li J; Zhao M; Wang J; Gu YY; Li Y; Yuan P; Zhao GH; Huang CZ
Med Sci Monit; 2018 Apr; 24():2476-2488. PubMed ID: 29683112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]